SUBSTITUTED 6, 7-DIALKOXY-3-ISOQUINOLINE DERIVATIVES AS INHIBITORS OF PHOSPHODIESTERASE 10 (PDE 10A)
申请人:Allergan, Inc.
公开号:US20150158895A1
公开(公告)日:2015-06-11
The invention relates to compounds of the formula
or a pharmaceutically acceptable salt thereof, wherein R′, R
1
through R
7
and Ar are as defined herein. These compounds are useful as inhibitors of phosphodiesterase 10 (PDE10A) which are useful in treating central nervous system diseases such as psychosis and also in treating, for example, obesity, type II diabetes, metabolic syndrome, glucose intolerance, pain and ophthalmic diseases.
本发明涉及具有以下公式的化合物,或其药用可接受盐,其中R',R1至R7和Ar如本文所述定义。这些化合物作为磷酸二酯酶10(PDE10A)的抑制剂,可用于治疗中枢神经系统疾病,如精神疾病,也可用于治疗例如肥胖、II型糖尿病、代谢综合征、葡萄糖不耐症、疼痛和眼科疾病。